Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE, also known as 2-Bromo-1-(2-bromophenyl)-1H-indole-2,3-dione, is a chemical compound that belongs to the indole class. It is a yellow solid characterized by the presence of a bromine atom attached to the benzene ring of the indole structure. 1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE is typically used in organic synthesis and medicinal chemistry research due to its potential pharmacological properties, including anti-inflammatory and anti-cancer activities. Its unique chemical structure and reactivity make it a valuable tool for drug discovery and development efforts.

689757-55-9

Post Buying Request

689757-55-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

689757-55-9 Usage

Uses

Used in Pharmaceutical Industry:
1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE is used as a chemical intermediate for the development of new drugs, particularly in the pharmaceutical industry. Its chemical structure and reactivity contribute to the synthesis of various compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE is used as a research compound to study its pharmacological properties. 1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE has been investigated for its anti-inflammatory and anti-cancer activities, which could lead to the development of novel therapeutic agents.
Used in Organic Synthesis:
1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE is also utilized in organic synthesis as a key building block for the creation of more complex molecules. Its unique structure allows for further functionalization and modification, making it a versatile component in the synthesis of various organic compounds.
Used in Drug Discovery:
1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE is employed in drug discovery efforts due to its potential pharmacological properties. Researchers use 1-(2-BROMOBENZYL)-1H-INDOLE-2,3-DIONE to identify and develop new drug candidates with improved efficacy and safety profiles for the treatment of various diseases, including cancer and inflammatory conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 689757-55-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,9,7,5 and 7 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 689757-55:
(8*6)+(7*8)+(6*9)+(5*7)+(4*5)+(3*7)+(2*5)+(1*5)=249
249 % 10 = 9
So 689757-55-9 is a valid CAS Registry Number.

689757-55-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-Bromobenzyl)-1H-indole-2,3-dione

1.2 Other means of identification

Product number -
Other names 6,7-Dimethoxy-1-<2-brom-benzyl>-3,4-dihydro-isochinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:689757-55-9 SDS

689757-55-9Relevant academic research and scientific papers

Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors

Zhao, Xuelian,Zhan, Xuehui,Zhang, Huilin,Wan, Yichao,Yang, Huizhong,Wang, Yutian,Chen, Yanda,Xie, Wenlin

supporting information, (2021/11/16)

A series of (Z)-3-(2-(1,3,4-thiadiazol-2-yl)hydrazono)-1-substituted indolin-2-ones derivatives (3a-3m) were designed and synthesized. All newly synthesized compounds were evaluated for their a-glucosidase inhibitory activity with resveratrol as positive control in vitro. Except for 3i and 3j, all of the compounds showed a potent inhibitory activity against a-glucosidase with IC50 values in the range of 3.12 ± 1.25 to 45.95 ± 1.26 μM and the purity of these compounds was greater than 95%. The IC50 values were being compared to the standard resveratrol (IC50 = 22.00 ± 1.15 μM) and it was found that compounds 3b, 3d-3h were found to be more active than resveratrol. Specifically, (Z)-3-(2-(1,3,4-thiadiazol-2-yl)hydrazono)-1-(4-chlorobenzyl)indolin-2-one (3d) exhibited the most potent a-glucosidase inhibitory activity with IC50 value of 3.12 ± 1.25 μM. The kinetic analysis revealed that compound (3d) is noncompetitive inhibitor. Structure activity relationship has been established for all compounds. Furthermore, the binding interactions of compound 3d with the active site of a-glucosidase were confirmed through molecular docking. This study has identified a new class of potent a-glucosidase inhibitors for further investigation.

Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents

Patel, Dushyant V.,Patel, Nirav R.,Kanhed, Ashish M.,Patel, Sagar P.,Sinha, Anshuman,Kansara, Deep D.,Mecwan, Annie R.,Patel, Sarvangee B.,Upadhyay, Pragnesh N.,Patel, Kishan B.,Shah, Dharti B.,Prajapati, Navnit K.,Murumkar, Prashant R.,Patel, Kirti V.,Yadav, Mange Ram

, p. 3635 - 3661 (2019/08/20)

The multifaceted nature of Alzheimer's disease (AD) demands treatment with multitarget-directed ligands (MTDLs) to confront the key pathological aberrations. A novel series of triazinoindole derivatives were designed and synthesized. In vitro studies revealed that all the compounds showed moderate to good anticholinesterase activity; the most active compound 23e showed an IC50 value of 0.56 ± 0.02 μM for AChE and an IC50 value of 1.17 ± 0.09 μM for BuChE. These derivatives are also endowed with potent antioxidant activity. To understand the plausible binding mode of the compound 23e, molecular docking studies and molecular dynamics simulation studies were performed, and the results indicated significant interactions of 23e within the active sites of AChE as well as BuChE. Compound 23e successfully diminished H2O2-induced oxidative stress in SH-SY5Y cells and displayed excellent neuroprotective activity against H2O2 as well as Aβ-induced toxicity in SH-SY5Y cells in a concentration dependent manner. Furthermore, it did not show any significant toxicity in neuronal SH-SY5Y cells in the cytotoxicity assay. Compound 23e did not show any acute toxicity in rats at doses up to 2000 mg/kg, and it significantly reversed scopolamine-induced memory deficit in mice model. Additionally, compound 23e showed notable in silico ADMET properties. Taken collectively, these findings project compound 23e as a potential balanced MTDL in the evolution process of novel anti-AD drugs.

Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives

Wang, Guangcheng,Chen, Ming,Qiu, Jie,Xie, Zhenzhen,Cao, Anbai

, p. 113 - 116 (2017/12/11)

A novel series of chromone-isatin derivatives 6a–6p were designed, synthesized and characterized by 1H NMR, 13C NMR and HRMS. These novel synthetic compounds were evaluated for inhibitory activity against yeast α-glucosidase enzyme. The results of biological test have shown that all tested compounds exhibited excellent to potent inhibitory activity in the range of IC50 = 3.18 ± 0.12–16.59 ± 0.17 μM as compared to the standard drug acarbose (IC50 = 817.38 ± 6.27 μM). Compound 6j (IC50 = 3.18 ± 0.12 μM) with a hydroxyl group at the 7-position of chromone and a 4-bromobenzyl group at the N1-positions of isatin, was found to be the most active compound among the series. Furthermore, molecular docking study was performed to help understand binding interactions of the most active analogs with α-glucosidase enzyme. These results indicated that this class of compounds had potential for the development of anti-diabetic agents.

Scaffold-inspired enantioselective synthesis of biologically important spiro[pyrrolidin-3,2'-oxindoles] with structural diversity through catalytic isatin-derived 1,3-dipolar cycloadditions

Shi, Feng,Tao, Zhong-Lin,Luo, Shi-Wei,Tu, Shu-Jiang,Gong, Liu-Zhu

supporting information; experimental part, p. 6885 - 6894 (2012/07/27)

Catalytic asymmetric construction of the biologically important spiro[pyrrolidin-3,2'-oxindole] scaffold with contiguous quaternary stereogenic centers in excellent stereoselectivities (up to >99:1 d.r., 98 % ee) has been established by using an organocat

CH activation and CH2 double activation of indolines by radical translocation: Understanding the chemistry of the indolinyl radical

Harrowven, David C.,Stenning, Kerri J.,Whiting, Sally,Thompson, Toby,Walton, Robert

supporting information; experimental part, p. 4882 - 4885 (2011/08/05)

CH activation and CH2 double activation of indolines at C2 may be achieved efficiently through radical translocation. The fate of the C2 indolinyl radical is dictated by the substitution at C3. Fragmentation, cyclisation and tandem cyclisation reactions leading to indole, azaheterocycle and azapropellane formation, respectively, are reported. The Royal Society of Chemistry 2011.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 689757-55-9